Delivery Order SPE2DR25D1106-SPE2DR26FJB2X
- Not listed
- The Defense Logistics Agency awarded a $3,023.55 delivery order to AmerisourceBergen Drug Corp for Heparin 25,000 unit/250-1/2 normal saline 250ml pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on October 31, 2025, with an ultimate completion date of November 3, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,213 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Heparin Sodium 5,000 Unit/0.5 ML injectable medication, with completion scheduled for October 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order valued at $4,324.59 to AmerisourceBergen Drug Corp for the supply of Heparin 25,000 unit/250 ml in D5W solution (250 ml units). This firm fixed-price delivery order, awarded on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Heparin 1,000 Unit/500 mL in normal saline solution, 500 mL vials, with a ceiling value of $1,464.60. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion by September 11, 2025, and will be fulfilled from the contractor's location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Heparin 25,000 Unit/250 mL in 5% Dextrose Water (D5W) solution, with a ceiling value of $1,061.90. This competitive, firm fixed-price delivery order was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,968.72 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Heparin 25,000 unit/250 ml in D5W solution (250 ml units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,761.14 for Heparin 25,000 Unit/250 mL in D5W solution (250 mL units) on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,451.35 firm fixed price delivery order is for the supply of Heparin 25,000 unit/250 mL-D5W 250 mL medical products. The contract has an ultimate completion date of November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, valued at $1,036.50, is for the delivery of 4,564,414,960 units of 500 unit/5 ml heparin solution. This delivery order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $1,953.89, is for the delivery of 25,000 unit/250 ML heparin solutions in 250 ML bags. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJB2XDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,578.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Heparin Sodium 5,000 Unit/0.5 mL pharmaceutical product. This is a non-set-aside award issued on November 27, 2025, with an ultimate completion date of November 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle supporting federal medical procurement operations. This award is a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems, with demonstrated capability to fulfill competitive federal procurement requirements across diverse therapeutic domains. The underlying IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to support Department of Defense healthcare programs and other federal customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 11/26/25 |